Atypical molecular findings identify limits of technical screening tests for Prader-Willi and Angelman syndrome diagnoses
โ Scribed by Malzac, Perrine; Moncla, Anne; Pedeillier, Karinne; Van, Catherine Vo; Girardot, Lydie; Voelckel, Marie-Antoinette
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 11 KB
- Volume
- 78
- Category
- Article
- ISSN
- 0148-7299
- DOI
- 10.1002/(sici)1096-8628(19980707)78:3<242::aid-ajmg6>3.0.co;2-r
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
We report on a relatively large survey of Prader-Willi syndrome, Angelman syndrome, and control subjects with the newly described methylation polymerase chain reaction (PCR) method to determine its usefulness for molecular diagnosis. Sixty-one Prader-Willi syndrome (PWS) individuals (26 men and 35 w
The putative promoter region of the SNRPN gene contains a CpG island which is heavily methylated in the maternally derived allele and unmethylated in the paternally derived allele. In patients with Prader-Willi syndrome (PWS) only the methylated allele is present, while in those with Angelman syndro
Smith-Lemli-Opitz (SLO) syndrome is an autosomal recessive disorder comprised of recognizable facial abnormalities, growth retardation, and multiple congenital anomalies, commonly involving genitalia, second and third toe syndactyly, and cleft palate. The condition is associated with hypocholesterol
Several recent studies have suggested the presence of mosaicism for a deletion, detected by fluorescence in situ hybridization (FISH), within chromosome 15q11-q13 in Prader-Willi syndrome (PWS) [Mowery-Rushton et al., 1996;Malzac et al., 1998;Golden et al., 1999]. However, the evidence supporting mo